Finance

Beta
Roʻyxatlar
Aksiyalar sektorlari
Belgilar
Belgilar
Narxi
Oʻzgartirishlar
Dinamika (%)
Trend
Avvalgi yopilish narxi
Ochish
Yuqori
Past
Hajmi
Bozor kapitali
SIXB
Materials
SIXB
Materials
SIXB
+0,99%
1 093,81
+10,77
+0,99%
—1 083,041 082,631 099,011 080,59——
SIXC
Communications
SIXC
Communications
SIXC
+1,06%
608,77
+6,39
+1,06%
—602,38602,38609,75599,75——
SIXE
Energy
SIXE
Energy
SIXE
+0,96%
1 254,81
+11,98
+0,96%
—1 242,831 229,311 258,881 220,51——
SIXI
Industrials
SIXI
Industrials
SIXI
+2,76%
1 761,11
+47,29
+2,76%
—1 713,821 715,471 763,111 715,47——
SIXM
Financials
SIXM
Financials
SIXM
+0,40%
642,58
+2,59
+0,40%
—639,99636,98644,04631,81——
SIXR
Staples
SIXR
Staples
SIXR
+1,63%
851,13
+13,67
+1,63%
—837,46840,30852,55840,30——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1,76%
217,98
+3,76
+1,76%
—214,22214,22218,25214,05——
SIXT
Technology
SIXT
Technology
SIXT
+0,23%
3 211,83
+7,45
+0,23%
—3 204,383 215,043 217,443 159,90——
SIXU
Utilities
SIXU
Utilities
SIXU
+2,55%
948,98
+23,60
+2,55%
—925,38927,91949,76927,91——
SIXV
Health care
SIXV
Health care
SIXV
+2,20%
1 474,52
+31,81
+2,20%
—1 442,711 443,011 477,901 443,01——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1,30%
2 392,12
+30,78
+1,30%
—2 361,342 391,002 399,182 354,52——
Q1 2026 daromadi • 5 kundan keyin
Tafsilotlar
N1VO34:BVMF
Novo Nordisk Bdr
26,60 R$
+4,77%
(+1,21) 1K
30-apr, 17:10:00 (GMT-3)  ·   BRL
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
N1VO34 tikeri uchun statistika yaratilmoqda...
Ochish
25,93 R$
Yuqori
26,66 R$
Past
25,81 R$
Bozor kapitali
142,31 mlrd
Oʻrtacha hajm
21,68 ming
Hajmi
97,76 ming
52 haftalik eng yuqori
57,25 R$
52 haftalik eng past
22,90 R$
Muomaladagi aksiyalar
3,39 mlrd
Xodimlar soni
69 ming
Yangiliklar
Internetdagi manbalardan
Profil
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28.1% of its shares and a majority of its voting shares. Novo Nordisk manufactures and markets pharmaceutical products and services, specifically diabetes and obesity medications and devices. Novo Nordisk employs more than 48,000 people globally, and markets its products in 168 countries. The corporation was created in 1989, through a merger of two Danish companies, which date back to the 1920s. Novo Nordisk is a full member of the European Federation of Pharmaceutical Industries and Associations. The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo Nordisk was named the most sustainable company in the world by the business magazine Corporate Knights, while spin-off company Novozymes was named fourth. It is a leader in the FTSE4Good Index, and the only European company in the top ten. Novo Nordisk is the largest pharmaceutical company in Denmark. Wikipedia
Novo Nordisk Bdr haqida
CEOMaziar Mike Doustdar
Xodimlar soni69,2 ming
Asos solingan21-dek, 1923
Bosh ofislarBagsværd, Capital Region of Denmark, Daniya
Sektor-
Veb-saytnovonordisk.com
Keyingi hisobot: 5 kundan keyin
Chor, 6-may, 07:00
Moliya davri
Ch.1 2026
Normallashtirilgan EPS / Taxminiy
-/ (5,46 taxm.)DKK
Daromad / Taxminan
-/ (71,78 mlrd taxm.)DKK
Q1 2026 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
Qisqacha: kelgusi tushumlarOxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar – DKK
Loading Previous Earnings...
Daromad hisoboti
Daromad
Sof foyda
Barcha qiymatlar – DKK
mar, 2025
iyn, 2025
sen, 2025
dek, 2025
Daromad
78,09 mlrd
76,86 mlrd
74,98 mlrd
79,14 mlrd
Sotilgan mahsulotning tannarxi
12,89 mlrd
12,85 mlrd
14,47 mlrd
14,17 mlrd
Daromad narxi
12,89 mlrd
12,85 mlrd
14,47 mlrd
14,17 mlrd
Tadqiqot va ishlanmalarga xarajatlar
10,31 mlrd
11,69 mlrd
11,49 mlrd
12,67 mlrd
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
16,11 mlrd
18,85 mlrd
15,76 mlrd
17,14 mlrd
Operatsion xarajatlar
26,41 mlrd
30,56 mlrd
27,25 mlrd
29,73 mlrd
Jami operatsion xarajatlar
39,30 mlrd
43,41 mlrd
41,72 mlrd
43,90 mlrd
Operatsion daromad
38,79 mlrd
33,45 mlrd
33,25 mlrd
35,24 mlrd
Boshqa nooperatsion daromad
-
-
1,53 mlrd
-241,00 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
37,03 mlrd
33,80 mlrd
25,52 mlrd
34,18 mlrd
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
37,03 mlrd
33,80 mlrd
35,09 mlrd
37,62 mlrd
Daromad soligʻi boʻyicha xarajat
8,00 mlrd
7,30 mlrd
5,51 mlrd
7,29 mlrd
Amaldagi soliq stavkasi
21,60%
21,60%
21,60%
21,34%
Boshqa operatsion xarajatlar
-14,00 mln
23,00 mln
-
-81,00 mln
Sof foyda
29,03 mlrd
26,50 mlrd
20,01 mlrd
26,89 mlrd
Sof foyda marjasi
37,18%
34,48%
26,68%
33,98%
Har bir aksiya foydasi
6,53
5,96
4,50
6,04
Foizlar va investitsiyalardan olingan daromadlar
3,42 mlrd
5,31 mlrd
307,00 mln
4,41 mlrd
Foizlarni toʻlash xarajatlari
-3,86 mlrd
-4,96 mlrd
-
-4,97 mlrd
Foizlarni toʻlash boʻyicha sof xarajatlar
-433,00 mln
356,00 mln
307,00 mln
-560,00 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
42,62 mlrd
37,65 mlrd
36,49 mlrd
36,66 mlrd
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish

Tahlil

Vazifalarim
Hali vazifa yaratmagansiz
Vazifalaringiz shu yerda chiqadi. Vazifalarni rejalashtiring va Google Finance xizmatidan foydalaning.
Andozalar
Kuzatuv roʻyxati brifingi
Kuzatuv roʻyxatining kunlik bozor oldidan tahlili
Kelgusi tushumlar
Hafta ichida kelgusi tushum hisobotlari
Anomal volatillik va hajm
Bugun erta ogohlantirish: volatillik va hajm
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish